This exploration was carried out To guage the opportunity of your CPPs with tumor-targeting properties to provide a cytotoxic payload to HCC cells. We explored employing a CXCR4-focusing on peptide, T22, fused with cytotoxic peptide PE24, being a novel therapeutic strategy for CXCR4+ HCC cells. T22 was selected as the https://billyu639eim2.scrappingwiki.com/user